- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07735884
Comparison of Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Tramadol for Positioning of Femur Fracture Patients Before Spinal Anaesthesia
This randomized clinical study compared two methods of pain relief used before spinal anaesthesia in patients undergoing surgery for a femur fracture. Positioning a patient with a fractured femur into the side-lying position required for spinal anaesthesia can cause severe pain because movement may disturb the fractured bone.
A total of 64 patients aged 18 to 60 years were included and were assigned to one of two treatment groups. One group received intravenous tramadol, while the other group received an ultrasound-guided fascia iliaca compartment block, in which local anaesthetic was injected near the nerves supplying the hip and upper thigh. Pain was measured using a visual analogue scale when the patient arrived on the operating table and again during positioning in the lateral decubitus position before spinal anaesthesia.
The study was conducted to determine which treatment provided better pain relief and made positioning for spinal anaesthesia more comfortable. It was hypothesized that the ultrasound-guided fascia iliaca compartment block would reduce pain during positioning more effectively than intravenous tramadol.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Mayo Hospital, Lahore
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18-60 years
- Male or female patients
- American Society of Anesthesiologists physical status I or II
- Patients scheduled for femur fracture surgery under spinal anaesthesia
Exclusion Criteria:
- Multiple fractures
- Peripheral neuropathy
- Inability to communicate or provide reliable pain assessment
- History of allergy to local anaesthetic agents
Contraindication to spinal anaesthesia, including:
- Patient refusal
- Local infection at the injection site
- Coagulopathy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Ultrasound-Guided Fascia Iliaca Compartment Block Group
Participants received an ultrasound-guided fascia iliaca compartment block through the infrainguinal approach using 30 mL of 1% lidocaine with adrenaline.
After 15 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
An ultrasound-guided infrainguinal fascia iliaca compartment block was administered with 30 mL of 1% lidocaine containing adrenaline.
|
|
Comparateur actif: Intravenous Tramadol Group
Participants received intravenous tramadol at a dose of 1 mg/kg.
After 10 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
Tramadol was administered intravenously at a dose of 1 mg/kg before positioning for spinal anaesthesia.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain Intensity During Positioning for Spinal Anaesthesia
Délai: 10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Pain intensity was assessed using a 0-10 visual analogue scale during placement of the participant in the lateral decubitus position before spinal anaesthesia.
A score of 0 represented no pain, while a score of 10 represented the worst possible pain.
Lower scores indicated better analgesic efficacy.
|
10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Visual Analogue Scale Pain Score From Baseline to Positioning
Délai: 10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
The change in pain intensity was determined by comparing the visual analogue scale score recorded while the participant was lying on the operating table before the assigned intervention with the score recorded during lateral decubitus positioning.
A greater reduction in score indicated greater analgesic effectiveness.
|
10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Adeel Ahmed, Mayo Hospital Lahore
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- La douleur
- Manifestations neurologiques
- Blessures et Blessures
- Blessures aux jambes
- Fractures, Os
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Fracture fémorale
- La douleur aiguë
- Produits chimiques organiques
- Lipides
- Amines
- Alcools
- Cyclohexanols
- Hexanols
- Alcools gras
- Diméthylamines
- Méthylamines
- Tramadol
Autres numéros d'identification d'étude
- Mayo8
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .